BioNTech SE Ownership | Who Owns BioNTech SE?

BioNTech SE Ownership Summary

BioNTech SE is owned by 7.10% institutional investors, 56.77% insiders, and 36.13% retail investors. Fmr is the largest institutional shareholder, holding 2.26% of BNTX shares. Franklin All Country World ex US Equity is the top mutual fund, with 8.32% of its assets in BioNTech SE shares.

BNTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	BioNTech SE	7.10%	56.77%	36.13%
Sector	Healthcare Stocks	232.86%	10.65%	-143.51%
Industry	Biotech Stocks	382.13%	10.41%	-292.54%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	5.45M	2.26%	$537.82M
T. rowe price investment management	4.83M	2.00%	$476.69M
Flossbach von storch	4.20M	1.75%	$399.46M
Primecap management co/ca/	3.80M	1.59%	$361.76M
Dodge & cox	3.65M	1.51%	$359.68M
Blackrock	1.90M	0.79%	$152.32M
Bnp paribas arbitrage, snc	1.58M	0.66%	$150.23M
Temasek (private)	1.51M	0.62%	$148.52M
Jane street group	1.36M	0.57%	$129.59M
Baillie gifford	1.24M	0.52%	$118.51M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bill & melinda gates foundation	148.67K	19.99%	$11.95M
Gsk	889.82K	10.60%	$84.71M
Logos global management lp	300.00K	4.00%	$34.19M
Krensavage asset management	79.37K	3.33%	$7.83M
Crocodile capital partners gmbh	29.59K	2.02%	$2.82M
Flossbach von storch	4.20M	1.58%	$399.46M
Sectoral asset management	17.22K	1.31%	$1.64M
Long focus capital management	397.65K	1.30%	$39.22M
Gardner lewis asset management l p	49.38K	1.19%	$4.70M
Centerbook partners lp	236.18K	1.10%	$22.48M

Top Buyers

Holder	Shares	% Assets	Change
Dodge & cox	3.65M	0.19%	2.77M
T. rowe price investment management	4.83M	0.29%	1.24M
Jane street group	1.36M	0.02%	1.16M
Gsk	889.82K	10.60%	889.82K
Bnp paribas arbitrage, snc	1.58M	0.07%	474.80K

Top Sellers

Holder	Shares	% Assets	Change
Baillie gifford	1.24M	0.10%	-6.63M
Fmr	5.45M	0.03%	-2.71M
Pfizer	-	-	-1.66M
Capital world investors	-	-	-955.98K
Viking global investors lp	-	-	-879.97K

New Positions

Holder	Shares	% Assets	Change	Value
Gsk	889.82K	10.60%	889.82K	$84.71M
Logos global management lp	300.00K	4.00%	300.00K	$34.19M
Ghisallo capital management	125.00K	0.40%	125.00K	$12.33M
Gardner lewis asset management l p	49.38K	1.19%	49.38K	$4.70M
Campbell & co investment adviser	46.90K	0.21%	46.90K	$4.46M

Sold Out

Holder	Change
Halbert hargrove global advisors	-1.00
Clear street markets	-1.00
Gps wealth strategies group	-1.00
Cornerstone planning group	-1.00
Harbor investment advisory	-1.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	143	-50.35%	16,971,235	-66.39%	7	1.62%	60	-43.40%	37	-59.78%
Sep 30, 2025	105	-62.09%	20,093,114	-62.09%	8	1.71%	36	-70.97%	37	-51.32%
Jun 30, 2025	283	-8.41%	53,736,135	4.22%	22	4.86%	122	11.93%	80	-22.33%
Mar 31, 2025	310	-8.55%	51,726,357	1.91%	21	4.80%	108	-28.95%	105	23.53%
Dec 31, 2024	329	-2.37%	50,653,251	14.51%	21	6.21%	146	-7.59%	84	-4.55%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Franklin All Country World ex US Equity	20.00M	8.32%	20.00M
FvS SICAV Multiple Opportunities F	2.73M	1.08%	-
Dodge & Cox International Stock I	2.52M	1.00%	-
T. Rowe Price Capital Appreciation	2.27M	0.90%	828.70K
Vanguard Capital Opportunity Inv	2.19M	0.87%	-22.02K
Fidelity Contrafund	1.42M	0.57%	193.32K
Harding Loevner International Eq Instl	1.29M	0.54%	-561.45K
FvS Multiple Opportunities II I	1.17M	0.46%	-
T. Rowe Price US Mid-Cap Growth Equity	1.02M	0.41%	-1.40K
T. Rowe Price Mid-Cap Growth	1.02M	0.40%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Apr 22, 2026	Poetting Sierk	Chief Operating Officer	Sell	$5.53M

Insider Transactions Trends

Date	Buy	Sell
2029 Q2	-	-
2027 Q2	-	-
2026 Q2	-	-
2026 Q1	-	-
2025 Q2	-	-

BNTX Ownership FAQ

Who Owns BioNTech SE?

BioNTech SE shareholders are primarily institutional investors at 7.10%, followed by 56.77% insiders and 36.13% retail investors. The average institutional ownership in BioNTech SE's industry, Biotech Stocks , is 382.13%, which BioNTech SE falls below.

Who owns the most shares of BioNTech SE?

BioNTech SE’s largest shareholders are Fmr (5.45M shares, 2.26%), T. rowe price investment management (4.83M shares, 2.00%), and Flossbach von storch (4.2M shares, 1.75%). Together, they hold 6.01% of BioNTech SE’s total shares outstanding.

Does Blackrock own BioNTech SE?

Yes, BlackRock owns 0.79% of BioNTech SE, totaling 1.9M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 152.32M$. In the last quarter, BlackRock decreased its holdings by -11.414K shares, a -0.60% change.

Who is BioNTech SE’s biggest shareholder by percentage of total assets invested?

Bill & melinda gates foundation is BioNTech SE’s biggest shareholder by percentage of total assets invested, with 19.99% of its assets in 148.67K BioNTech SE shares, valued at 11.95M$.

Who is the top mutual fund holder of BioNTech SE shares?

Franklin All Country World ex US Equity is the top mutual fund holder of BioNTech SE shares, with 8.32% of its total shares outstanding invested in 20M BioNTech SE shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools